OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
43
Results
Show all
Save search
Copy query
Show results for
Unknown
(41)
Genomics
(2)
Organisms
Homo sapiens
(2)
Repository
EGA
(2)
Publication Date
Release Date
2020
(18)
2015
(4)
2022
(3)
2019
(3)
2014
(3)
2021
(2)
2018
(2)
2017
(2)
2016
(2)
2024
(1)
2009
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
High-Throughput, Amplicon-Based Sequencing of the CREBBP Gene as a Tool to Develop a Universal Platform-Independent Assay.
Not available
S-EPMC4461278
|
biostudies-literature
Cite
Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30.
Not available
S-EPMC4760288
|
biostudies-literature
Cite
CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis.
Not available
S-EPMC9562902
|
biostudies-literature
Cite
Patient specific real-time PCR in precision medicine - Validation of IG/TR based MRD assessment in lymphoid leukemia.
Not available
S-EPMC9885152
|
biostudies-literature
Cite
Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.
Not available
S-EPMC3912981
|
biostudies-literature
Cite
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab.
Not available
S-EPMC6356981
|
biostudies-literature
Cite
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).
Not available
S-EPMC4825288
|
biostudies-literature
Cite
Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations.
Not available
S-EPMC9642790
|
biostudies-literature
Cite
Hematopoietic stem cell involvement in
BCR-ABL1-
positive ALL as a potential mechanism of resistance to blinatumomab therapy.
Not available
S-EPMC5726343
|
biostudies-literature
Cite
Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.
Not available
S-EPMC5332302
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
